TY - JOUR
T1 - Preparedness and Response Considerations for High-Consequence Infectious Disease
AU - Basic and Translational State of the Science Working Group of the National Emerging Special Pathogens Training and Education Center’s Special Pathogens Research Network
AU - Chan, Justin
AU - Levine, Corri B.
AU - Herstein, Jocelyn J.
AU - Cloutier, Nicole
AU - Sauer, Lauren
AU - Mehta, Aneesh K.
AU - Evans, Jared
N1 - Publisher Copyright:
© 2025, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2025/8
Y1 - 2025/8
N2 - High-consequence infectious diseases (HCIDs) are acute human infectious diseases with high illness and case-fatality rates, few or no available effective treatment or prevention options, and the ability to spread in the community and within healthcare settings. Those characteristics lead to significant risks to patients and their close contacts, healthcare workers, laboratory personnel, and communities exposed to an outbreak. We describe aspects of healthcare system preparedness for and response to HCIDs, including the role of high-level isolation units, ensuring safe clinical laboratory capabilities and waste management, increasing availability of medical countermeasures, coordinating with stakeholders and systems of care, and communicating with the public. Finally, we discuss priority areas for further investment in HCID preparedness, care, and research. Effective and equitably disseminated medical countermeasures for HCIDs are urgently needed.
AB - High-consequence infectious diseases (HCIDs) are acute human infectious diseases with high illness and case-fatality rates, few or no available effective treatment or prevention options, and the ability to spread in the community and within healthcare settings. Those characteristics lead to significant risks to patients and their close contacts, healthcare workers, laboratory personnel, and communities exposed to an outbreak. We describe aspects of healthcare system preparedness for and response to HCIDs, including the role of high-level isolation units, ensuring safe clinical laboratory capabilities and waste management, increasing availability of medical countermeasures, coordinating with stakeholders and systems of care, and communicating with the public. Finally, we discuss priority areas for further investment in HCID preparedness, care, and research. Effective and equitably disseminated medical countermeasures for HCIDs are urgently needed.
UR - https://www.scopus.com/pages/publications/105012317587
UR - https://www.scopus.com/pages/publications/105012317587#tab=citedBy
U2 - 10.3201/eid3108.250313
DO - 10.3201/eid3108.250313
M3 - Article
C2 - 40705034
AN - SCOPUS:105012317587
SN - 1080-6040
VL - 31
SP - 1507
EP - 1515
JO - Emerging infectious diseases
JF - Emerging infectious diseases
IS - 8
ER -